
A quick look at the history of OTC dosage form development shows the importance of patient-centered innovation.
Gerry P. McNally is principal of McNally Consulting Group, LLC. With more than 25 years of experience, he earned a BS and PhD in chemistry from University College, Dublin, Ireland and holds more than 25 patents in drug delivery and formulation. He can be reached at gmcnally47@aol.com.

Published: April 6th 2020 | Updated: